Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn I Levin

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 21, 2022
Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL SubtypesLynn I Levin, Christina M Ramirez, Eileen L Liao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 26, 2017
Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma DiagnosisLynn I Levin, Elizabeth C Breen, Brenda M Birmann, et al.
Blood|September 14, 2012
Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphomaLynn I Levin, Ellen T Chang, Richard F Ambinder, et al.
International Journal of Cancer|September 24, 2022
Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysisJongeun Rhee, Brenda M Birmann, Anneclaire J De Roos, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 21, 2022
Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL SubtypesLynn I Levin, Christina M Ramirez, Eileen L Liao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 26, 2017
Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma DiagnosisLynn I Levin, Elizabeth C Breen, Brenda M Birmann, et al.
Blood|September 14, 2012
Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphomaLynn I Levin, Ellen T Chang, Richard F Ambinder, et al.
International Journal of Cancer|September 24, 2022
Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysisJongeun Rhee, Brenda M Birmann, Anneclaire J De Roos, et al.
Pageof 2